The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cardiovascular risk factor control and risk of future cardiovascular events in survivors of childhood cancer: A report from the St. Jude Lifetime cohort.
 
Stephanie Dixon
Employment - Pacemate (I)
Travel, Accommodations, Expenses - Pacemate (I)
 
Yan Chen
No Relationships to Disclose
 
Sedigheh Mirzaei
No Relationships to Disclose
 
Matthew Ehrhardt
Honoraria - Amgen; Optum; PlatformQ Health
Research Funding - Pfizer; Seagen
Travel, Accommodations, Expenses - Amgen
Other Relationship - Children's Oncology Group Foundation
 
Daniel Mulrooney
No Relationships to Disclose
 
Aron Onerup
No Relationships to Disclose
 
Carmen Wilson
No Relationships to Disclose
 
Angela Delaney
No Relationships to Disclose
 
Daniel Green
Patents, Royalties, Other Intellectual Property - Royalty from Up To Date
 
John Lucas
No Relationships to Disclose
 
Hiroto Inaba
Consulting or Advisory Role - Amgen; Jazz Pharmaceuticals
 
Jason Johnson
No Relationships to Disclose
 
Isaac Rhea
Research Funding - Pfizer
 
Vijaya Joshi
No Relationships to Disclose
 
Deokumar Srivastava
Consulting or Advisory Role - General Dynamics Information Technology
 
Kirsten Ness
Consulting or Advisory Role - City of Hope
 
Melissa Hudson
Employment - Methodist Hospital (I)
Consulting or Advisory Role - Princess Máxima Center; VIVA Foundation Singapore
 
Gregory Armstrong
No Relationships to Disclose
 
Bonnie Ky
Honoraria - UpToDate
Consulting or Advisory Role - American College of Cardiology; AstraZeneca
Research Funding - Pfizer
Patents, Royalties, Other Intellectual Property - Have a patent on the use of neuregulin-1b as a biomarker in heart failure